Clavulanic acid production by the MMS 150 mutant obtained from wild type Streptomyces clavuligerus ATCC 27064

Brazilian Journal of Microbiology
2014.0

Abstract

Clavulanic acid (CA) is a powerful inhibitor of the beta-lactamases, enzymes produced by bacteria resistants to penicillin and cefalosporin. This molecule is produced industrially by strains of Streptomyces clavuligerus in complex media which carbon and nitrogen resources are supplied by inexpensive compounds still providing high productivity. The genetic production improvement using physical and chemical mutagenic agents is an important strategy in programs of industrial production development of bioactive metabolites. However, parental strains are susceptible to loss of their original productivity due genetic instability phenomenona. In this work, some S. clavuligerus mutant strains obtained by treatment with UV light and with MMS are compared with the wild type (Streptomyces clavuligerus ATCC 27064). The results indicated that the random mutations originated some strains with different phenotypes, most divergent demonstrated by the mutants strains named AC116, MMS 150 and MMS 54, that exhibited lack of pigmentation in their mature spores. Also, the strain MMS 150 presented a larger production of CA when cultivated in semi-synthetics media. Using other media, the wild type strain obtained a larger CA production. Besides, using the modifed complex media the MMS 150 strain showed changes in its lipolitic activity and a larger production of CA. The studies also allowed finding the best conditions for a lipase activity exhibited by wild type S. clavuligerus and the MMS150 mutant.

Knowledge Graph

Similar Paper

Clavulanic acid production by the MMS 150 mutant obtained from wild type Streptomyces clavuligerus ATCC 27064
Brazilian Journal of Microbiology 2014.0
Clavulanic acid production by Streptomyces clavuligerus: biogenesis, regulation and strain improvement
The Journal of Antibiotics 2013.0
Improvement for the production of clavulanic acid by mutant Streptomyces clavuligerus
Letters in Applied Microbiology 2002.0
An Approach to Strain Improvement and Enhanced Production of Clavulanic Acid in<i>Streptomyces clavuligerus</i>
Bioscience, Biotechnology, and Biochemistry 2009.0
Screening of wild type Streptomyces isolates able to overproduce clavulanic acid
Brazilian Journal of Microbiology 2014.0
Clavulanic acid biosynthesis and genetic manipulation for its overproduction
Applied Microbiology and Biotechnology 2010.0
Improved production of clavulanic acid by reverse engineering and overexpression of the regulatory genes in an industrial <i>Streptomyces clavuligerus</i> strain
Journal of Industrial Microbiology and Biotechnology 2019.0
Proteome-wide alterations in an industrial clavulanic acid producing strain of Streptomyces clavuligerus
Synthetic and Systems Biotechnology 2017.0
Proteomics analysis of global regulatory cascades involved in clavulanic acid production and morphological development in<i>Streptomyces clavuligerus</i>
Journal of Industrial Microbiology and Biotechnology 2016.0
Clavulanic acid, a β-lactamase inhibitor: biosynthesis and molecular genetics
Applied Microbiology and Biotechnology 2000.0